Hypopigmented or Depigmented? Why That One Word Changes Everything About a White Patch

When a pale patch appears on the skin, most people reach for the same word: vitiligo. It is the diagnosis everyone has heard of, and the one that carries the most emotional weight. But dermatologists start somewhere quieter. Before naming a disease, they ask a narrower question: is this patch hypopigmented, meaning it still contains some melanin, or depigmented, meaning the pigment is essentially gone? That single distinction eliminates more wrong diagnoses than any blood test.

The biology behind the difference is straightforward. Skin color comes from melanocytes, pigment-producing cells scattered along the base of the epidermis, which package melanin into granules and hand them off to surrounding skin cells. A patch can turn lighter in two broad ways. In the first, melanocytes survive but underperform: inflammation, infection, or irritation disrupts pigment production or transfer, so the area fades but keeps a trace of color. In the second, melanocytes are destroyed or driven out entirely, and the skin loses pigment altogether. Vitiligo belongs to the second category. It is an autoimmune process in which the body's own T cells target melanocytes, and the resulting patches are typically stark, chalk white, and sharply bordered.

Most of vitiligo's look-alikes belong to the first category. Pityriasis alba, common in children and in people with eczema-prone skin, produces slightly scaly, poorly defined light patches, often on the cheeks and upper arms. The melanocytes are still there; low-grade inflammation has simply dialed down their output. Post-inflammatory hypopigmentation follows the same logic after a burn, a healed rash, psoriasis, or an aggressive cosmetic procedure: the injury temporarily disrupts pigment transfer, and color usually drifts back over months as the skin recovers. Tinea versicolor, caused by an overgrowth of Malassezia yeast, lightens skin through a different mechanism: the organism produces azelaic acid, which inhibits tyrosinase, the key enzyme in melanin synthesis. The patches are often faintly scaly and cluster on the chest, back, and shoulders, especially after sweaty summers.

This is where the clinician's most useful tool comes in: the Wood's lamp, a handheld ultraviolet light used in a darkened room. Under this light, fully depigmented skin fluoresces a bright, almost glowing blue white, because there is no melanin left to absorb the UV. Vitiligo lights up dramatically and its borders become crisp, sometimes revealing patches invisible in daylight. Hypopigmented conditions behave differently: pityriasis alba and post-inflammatory changes appear only slightly accentuated, and tinea versicolor often shows a yellowish or coppery tinge from the yeast itself. The exam takes under a minute, involves no needles, and frequently settles the question on the spot.

Why does the label matter so much in practice? Because the treatments diverge completely. Tinea versicolor responds to antifungal washes and creams, and treating it as vitiligo would waste months. Pityriasis alba usually needs little more than moisturizer, gentle skin care, and sometimes a short course of a mild anti-inflammatory, plus reassurance that repigmentation is the norm. Post-inflammatory hypopigmentation mostly needs time. Vitiligo, by contrast, is managed as an immune-mediated disease: topical corticosteroids or calcineurin inhibitors, narrowband UVB phototherapy, and more recently topical JAK inhibitors that interrupt the interferon gamma signaling loop driving melanocyte attack. Early, accurate diagnosis also matters for vitiligo specifically, because repigmentation depends on melanocyte reservoirs in hair follicles, and patches treated earlier tend to respond better than long-established ones.

A few practical caveats keep the picture honest. Very fair skin can make the hypo versus depigmented distinction harder to see with the naked eye, which is exactly when the Wood's lamp earns its keep. Early vitiligo can begin as a lighter, not fully white, patch, so a single exam is not always final; clinicians sometimes re-examine after a few months. There are also rarer entities in the mix, including nevus depigmentosus, a stable birthmark-like patch present from early childhood, and idiopathic guttate hypomelanosis, the small confetti-like light spots that accumulate on sun-exposed arms and shins with age. Neither behaves like vitiligo, and neither needs vitiligo treatment.

The takeaway is simple but genuinely useful. A white patch is a finding, not a diagnosis. Before assuming vitiligo, it is worth asking the clinician's first question: is pigment reduced, or is it gone? If a patch is faint, slightly scaly, fuzzy at the edges, or appeared after a rash or injury, the odds favor a reversible hypopigmentation. If it is stark white, sharply bordered, and glowing under UV light, vitiligo moves to the top of the list, and the conversation shifts to immune-directed care. Getting that one word right, hypopigmented or depigmented, is the difference between watchful waiting, an antifungal wash, and a genuine autoimmune treatment plan.

Further reading: Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art (Int J Mol Sci 2023); Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis (J Dermatolog Treat 2022); Advances in vitiligo: Update on therapeutic targets (Front Immunol 2022).